| Authors: |
Trinh A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Trumpi K; Cancer Center UMC Utrecht, University Medical Center Utrecht, Utrecht, the Netherlands., De Sousa E Melo F; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Department of Molecular Oncology, Genentech Inc., South San Francisco, California., Wang X; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Biomedical Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong., de Jong JH; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Fessler E; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Kuppen PJ; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Reimers MS; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Swets M; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Koopman M; Cancer Center UMC Utrecht, University Medical Center Utrecht, Utrecht, the Netherlands., Nagtegaal ID; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Jansen M; Department of Pathology, Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Centre for Tumour Biology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Hooijer GK; Department of Pathology, Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Offerhaus GJ; Cancer Center UMC Utrecht, University Medical Center Utrecht, Utrecht, the Netherlands., Kranenburg O; Cancer Center UMC Utrecht, University Medical Center Utrecht, Utrecht, the Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Medema JP; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Markowetz F; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Vermeulen L; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. l.vermeulen@amc.uva.nl. |
